These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 5048687)

  • 1. [EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
    Lang HD; Reichenmiller HE; Tigges FJ; Braun HJ; Golisch G
    Med Klin; 1972 Jun; 67(26):916-21. PubMed ID: 5048687
    [No Abstract]   [Full Text] [Related]  

  • 2. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 4. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 5. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine should not be used as initial therapy in Wilson's disease.
    Brewer GJ
    Mov Disord; 1999 Jul; 14(4):551-4. PubMed ID: 10435490
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

  • 14. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotypies in Wilson's disease.
    Yorio AA; Mesri JC; Pagano MA; Lera G
    Mov Disord; 1997 Jul; 12(4):614-6. PubMed ID: 9251089
    [No Abstract]   [Full Text] [Related]  

  • 16. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist?
    Ibáñez-Samaniego L; Ochoa-Palominos A; Catalina-Rodríguez MV; Salcedo-Plaza M; Clemente-Ricote G
    Rev Esp Enferm Dig; 2015 Mar; 107(3):190-1. PubMed ID: 25733050
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
    Boudin G; Pépin B; Milhaud M; Jérome H; Pacilly A
    Rev Neurol (Paris); 1968 Jan; 118(1):27-35. PubMed ID: 5697565
    [No Abstract]   [Full Text] [Related]  

  • 19. Penicillamine: the treatment of first choice for patients with Wilson's disease.
    Walshe JM
    Mov Disord; 1999 Jul; 14(4):545-50. PubMed ID: 10435489
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.